Heidelberg University Eye Clinic

Global Pupillometer Market Analysis Report 2023: A $673.9 Million Market by 2030 - Digital and Video Pupillometers Transforming Diagnosis with Mobility and Efficiency - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 10, 2023
Optical, Health, Medical Devices, Prevalence, Nursing, Hospital, Overalls, DSM-IV codes, Pupilometer, USD, Pupillometry, PLR, Ophthalmology, Growth, Diagnosis, Digital, Heidelberg University Eye Clinic, Research, Pupil, Medical imaging, Video game

The global pupillometer market size is expected to reach USD 673.9 million by 2030, registering a CAGR of 6.85%

Key Points: 
  • The global pupillometer market size is expected to reach USD 673.9 million by 2030, registering a CAGR of 6.85%
    Adoption of pupillometry is on the rise as an assessment examination for diagnosing various health conditions.
  • This growth in adoption is leading to the development of advanced pupillometer devices for faster and more accurate diagnosis.
  • Pupillometers are widely being used in critical care units, as pupillometry is becoming a protocol for primary diagnosis.
  • Video pupillometer is preferred more, as it helps in capturing the entire procedure of pupil dilation in a more detailed manner.

Marietta Eye Clinic Expands to Cumming, GA with a New Location

Retrieved on: 
Thursday, July 6, 2023
Optical, Health, Family, Consumer, University of Central Florida College of Medicine, University, Florida State University, Medical college, Ophthalmology, Multimedia, GA, Optometry, Ribbon, Heidelberg University Eye Clinic, Patient, Medical College of Wisconsin, Knowledge, Forsyth County, Commerce, Hospital, Nursing

Marietta Eye Clinic is delighted to announce the grand opening of its newest location in Cumming, GA, further solidifying its commitment to providing exceptional eye care services.

Key Points: 
  • Marietta Eye Clinic is delighted to announce the grand opening of its newest location in Cumming, GA, further solidifying its commitment to providing exceptional eye care services.
  • (Photo: Business Wire)
    To commemorate this exciting expansion Marietta Eye Clinic held a Ribbon Cutting Ceremony with the Forsyth County Chamber of Commerce, which took place Wednesday, June 21, 2023, at 2:30 PM EDT.
  • With this new location, patients in Cumming, GA, and the surrounding areas can now access the same high-quality eye care services that Marietta Eye Clinic has been providing for over 55 years.
  • Discover the unparalleled care and expertise that Marietta Eye Clinic offers by scheduling an appointment today.

Celebrating 30 Years of the Toyota Production System Support Center

Retrieved on: 
Friday, March 24, 2023
SBP, Harbor–UCLA Medical Center, Travel, Toyota Production System, SBP (nonprofit organization), History, Eye, TPS, Toyota, Organization, Philosophy, Hospital, Heidelberg University Eye Clinic, Hurricane Katrina, MD, Patient, Ophthalmology, Government, Safety, Nursing

PLANO, Texas, March 24, 2023 /PRNewswire/ -- How does decades of assembling some of the world's best vehicles help improve small and mid-sized manufacturers, food banks, health care providers and government agencies?

Key Points: 
  • For more than 30 years, Toyota Production System Support Center (TSSC), a not-for-profit corporation, has shared its know-how with more than 500 partners.
  • Its teachings are based on the Toyota Production System (TPS), an organizational manufacturing culture and mindset that engages people to continuously make improvements and create solutions.
  • Utilizing TPS, TSSC operates on the philosophy that small improvements can make a big difference, not only inside Toyota but with outside organizations as well.
  • "This is our hospital, and Toyota came in to teach us how we can identify ways to do better.

The Worldwide Retinal Laser Equipment Industry is Expected to Reach $931.7 Million by 2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 13, 2023
Health, Optical, Hospital, Growth, Heidelberg University Eye Clinic, Pet

The global market for Retinal Laser Equipment estimated at US$572.1 Million in the year 2020, is projected to reach a revised size of US$931.7 Million by 2027, growing at a CAGR of 7.2% over the analysis period 2020-2027.

Key Points: 
  • The global market for Retinal Laser Equipment estimated at US$572.1 Million in the year 2020, is projected to reach a revised size of US$931.7 Million by 2027, growing at a CAGR of 7.2% over the analysis period 2020-2027.
  • Hospitals, one of the segments analyzed in the report, is projected to record a 7.6% CAGR and reach US$538.9 Million by the end of the analysis period.
  • The U.S. Market is Estimated at $155.9 Million, While China is Forecast to Grow at 11.5% CAGR
    The Retinal Laser Equipment market in the U.S. is estimated at US$155.9 Million in the year 2020.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$128.5 Million by the year 2027.

Global Ophthalmology EMR Software Market Report (2022-2027): Proliferation in Number of Ophthalmology Medical Records Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 22, 2022
Health, Health Technology, Cloud, Ansoff Matrix, SWOT, USD, Porter's five forces analysis, Risk, Growth, Patient, Investment, COVID-19, Observation, Market development, Geography, Heidelberg University Eye Clinic, Software, Hospital, Retail, Risk management

The Global Ophthalmology EMR Software Market is estimated to be USD 315.05 Mn in 2022 and is expected to reach USD 466.57 Mn by 2027, growing at a CAGR of 8.17%

Key Points: 
  • The Global Ophthalmology EMR Software Market is estimated to be USD 315.05 Mn in 2022 and is expected to reach USD 466.57 Mn by 2027, growing at a CAGR of 8.17%
    The Global Ophthalmology EMR Software Market is segmented based on Type, Product Type, End-Users, and Geography.
  • The report presents a detailed Ansoff matrix analysis for the Global Ophthalmology EMR Software Market.
  • The analyst analyses the Global Ophthalmology EMR Software Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • The report offers a comprehensive evaluation of the Global Ophthalmology EMR Software Market.

Ophthalmic Femtosecond Lasers Global Market Report 2022: Government Initiatives and Awareness Campaigns to Control Visual Impairment Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, December 2, 2022
Technology, Optical, Health, Hardware, Cataract surgery, Laser, Research, Refractive error, Value, Hospital, Strategic management, Use, Market share analysis, Acquisition, Economic development, Heidelberg University Eye Clinic, COVID-19, Business Growth Fund, Growth, Customer support, Retail, Application

The "Ophthalmic Femtosecond Lasers Market Research Report by Type, Product, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Ophthalmic Femtosecond Lasers Market Research Report by Type, Product, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
  • The Global Ophthalmic Femtosecond Lasers Market is projected to grow with a significant CAGR in the forecast period.
  • Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the Global Ophthalmic Femtosecond Lasers Market.
  • Based on Product, the market was studied across Diode Lasers, Excimer lasers, and Femtosecond Lasers.

Global Ophthalmology EMR Software Market to Reach $470.42 Million by 2027 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 6, 2022
Surgery, Health, Technology, Optical, Software, Cloud, Decision-making, Customer support, Heidelberg University Eye Clinic, Research, Ophthalmology, Software, USD, Personal Software Services, Patient, CAD, JPY, AUD, Business Growth Fund, Value, CHF, Use, Product type, CAGR, Market share analysis, Strategic management, GBP, Growth, Acquisition, Cryptocurrency, Hospital, Retail, EUR, Hospital

The Global Ophthalmology EMR Software Market size was estimated at USD 292.77 million in 2021, USD 316.10 million in 2022, and is projected to grow at a CAGR 8.22% to reach USD 470.42 million by 2027.

Key Points: 
  • The Global Ophthalmology EMR Software Market size was estimated at USD 292.77 million in 2021, USD 316.10 million in 2022, and is projected to grow at a CAGR 8.22% to reach USD 470.42 million by 2027.
  • The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF.
  • This research report categorizes the Ophthalmology EMR Software to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Type, the market was studied across Ambulatory EMR and Inpatient EMR.
  • Based on Product Type, the market was studied across Cloud-based Software Services and On-Premise Software Services.

EuroEyes signs tri-party agreement of mutual cooperation with leading medical universities in the PRC and Germany

Retrieved on: 
Friday, July 29, 2022
Group, Surgeon, Heidelberg University, Moran Eye Center, University, Education, AMC, Heidelberg University Eye Clinic, Doctor of Philosophy, Student, CEO, Entrepreneurship, Research, Zhejiang University School of Medicine, COVID-19, Second Affiliated Hospital of Xinjiang Medical University, Achievement, COO, Science, Patient, Medical school, International relations, Growth, JIN, HKEX, Chair, Hospital, Management, Pharmaceutical industry, Medicine, Ophthalmology, PRC, 2018 EuroEyes Cyclassics

HONG KONG, July 29, 2022 /PRNewswire/ -- EuroEyes International Eye Clinic Limited ("EuroEyes" or the "Company", together with its subsidiaries, the "Group", HKEX: 1846) announced on 27 July that it has signed a tri-party agreement of mutual cooperation ("AMC") with the Eye Center of Second Affiliated Hospital Zhejiang University School of Medicine, Zhejiang University Eye Hospital and The David J. Apple International Laboratory for Ocular Pathology & International Vision Correction Research Centre (IVCRC), University Eye Clinic of the Ruprecht-Karls-University of Heidelberg. The AMC aims to establish closer cooperation between eye care professionals in the PRC and Germany that could foster new innovations in ophthalmology, and enhance the skills of surgeons at EuroEyes and in the two countries who could contribute to the continued development in eye care.

Key Points: 
  • Jrn S. Jrgensen, Founder, Chairman and CEO of EuroEyes and Prof. Dr. Michael Knorz, EuroEyes Senior Vice President and Professor of Ophthalmology at University of Heidelberg, Medical Faculty Mannheim.
  • Ophthalmologists from EuroEyes, Heidelberg University Eye Clinicand Second Affiliated Hospital of Zhejiang University School of Medicine will have the opportunity to pursue a 3 to 6 months fellowship in the PRC and Germany.
  • We believe the collaboration will help EuroEyes identify talented students and surgeons in the PRC, offering them with local understandings, postgraduate experiences and knowledge exchanges in Germany.
  • Meanwhile, surgeons in Germany will be given opportunities to possess a wealth of on-the-ground experience in the PRC.

Kinarus Therapeutics to host KOL event on Monday, June 27, to discuss therapies in wet Age-Related Macular Degeneration and potential advantages of KIN001

Retrieved on: 
Friday, June 24, 2022
Biotechnology, Health, Pharmaceutical, Optical, Clinical Trials, Department, Institute, Knowledge, SELL, Patient, Research, Probability, Severe cognitive impairment, IPF, Chinese red-headed centipede, COVID-19, Heidelberg University Eye Clinic, CET, KNRS, University Hospital of Basel, Idiopathic pulmonary fibrosis, KOL, United States Medical Licensing Examination, Therapy, THE, Pioglitazone, INTO, Patent, Drug development, Severe acute respiratory syndrome coronavirus 2, Choroid, Eye, MD, MAPK, Pharmaceutical industry, Ophthalmology, Muthiri kinaru

Kinarus has received regulatory authorization to initiate Phase 2 testing of KIN001 to treat wet age-related macular degeneration (wAMD) as communicated previously on May 10, 2022.

Key Points: 
  • Kinarus has received regulatory authorization to initiate Phase 2 testing of KIN001 to treat wet age-related macular degeneration (wAMD) as communicated previously on May 10, 2022.
  • KIN001 has been shown to reduce pathological blood vessel growth (neovascularization) in the choroid of the eye in preclinical models of wAMD.
  • Kinarus CEO Alexander Bausch will present the KIN001 development plans in wAMD and other indications.
  • Investors can request to attend the KOL event in person or participate in the live video webcast of the KOL event.